from 24 to 30 October
Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting
Ernest Nadal
Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge
Microsoft Teams Meeting
21-22 October 2020
This event is being held online
Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich
Unitat EM HUB
22-23 Octubre 2020
Sala d’actes Bellvitge University hospital 9.00h
Speaker Eva Gonzalez-Suarez
Transformation and Metastasis Group, Oncobell Program
12-13 November 2020
this event is being held online
Rafael Máñez
Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
Microsoft Teams Meeting
By Joan Gómez Junyent
Directors: Javier Ariza Cardenal i Oscar Murillo Rubio
Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher
Online i en directe:
https://sinergia.l-h.cat/
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona
Microsoft Teams Meeting
Juan Jose Rojas
Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona
Microsoft Teams Meeting
Hèlix va néixer de la conversa entre Miquel Àngel Pujana, investigador de l’Institut d’Investigació Biomèdica de Bellvitge – Institut Català d’Oncologia i Magda Polo del grup d’investigació Ekho, de la Universitat de…
IDIBELL co-organizes the European Islet Study Group Conference 2026, a global meeting led by our researcher Meritxell…
We are pleased to announce the RegenBell 2026 symposium on Stem Cells and Regenerative Medicine, which will…
Glioblastoma (GB) is the most aggressive primary brain tumor, driven by constitutive activation of the epidermal growth…
Implications of a lung cancer screening programme in Spain Maria Olivia Cabrera Godoy – Health services research…
Dimarts 26 de maig a les 18 Sent el tumor més comú en homes, aquest s’origina quan…
28/05 09.00h (Biblioteca de Bellvitge) Would you like to take your research beyond the laboratory and connect…
Andrés Méndez Lucas – Nutrition, metabolism and gene therapy group Hosted by Isabel Fabregat Romero – TGF-beta…
The microbiota-gut-brain axis is emerging as a research area of increasing interest for those investigating the biological…
Blood Phytosterol Concentration and Genetic Variant Associations in Adult Population Leticia Garrido Sánchez – Pharmacotherapy, pharmacogenetics and…
